Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer clinical trials: development and implementation.

David M Vail1

  • 1Center for Clinical Trials and Research, School of Veterinary Medicine, University of Wisconsin-Madison, 2015 Linden Drive, Madison, WI 53706, USA. vaild@svm.vetmed.wisc.edu

The Veterinary Clinics of North America. Small Animal Practice
|October 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety evaluation of gilvetmab in dogs with melanoma and mast cell tumor.

Journal of veterinary internal medicine·2026
Same author

Safety and Feasibility of Infusing <i>Ex Vivo</i> Expanded Allogeneic Canine Natural Killer Cells for the Treatment of Metastatic Solid Tumors.

bioRxiv : the preprint server for biology·2026
Same author

SatTCR: a pipeline for performing saturation analysis of the T cell receptor repertoire and a case study of a healthy canine.

MethodsX·2025
Same author

Comparative transcriptomic analysis of tumor- infiltrating canine natural killer cells and candidate biomarkers from first-in-dog NK immunotherapy trials.

Frontiers in immunology·2025
Same author

Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma.

Frontiers in immunology·2025
Same author

In vitro detection of canine anti-human antibodies following intratumoral injection of the hu14.18-IL2 immunocytokine in spontaneous canine melanoma.

PloS one·2025

Veterinary oncology is improving with new clinical trials. Advanced trial designs in pets will enhance veterinary medicine and inform human cancer research.

Area of Science:

  • Veterinary Medicine
  • Oncology
  • Clinical Trials

Background:

  • Current veterinary oncology standards often rely on retrospective data or human studies.
  • A shift towards evidence-based practice is emerging in veterinary oncology.

Purpose of the Study:

  • To highlight the evolution of clinical trial methodologies in veterinary oncology.
  • To emphasize the importance of controlled, multicenter trials for advancing cancer treatment in companion animals.

Main Methods:

  • Increased focus on controlled, randomized, and blind multicenter trials.
  • Development of new cooperative investigative groups and consortia in veterinary oncology.

Main Results:

  • Controlled trials are becoming standard practice, moving beyond retrospective analysis.

Related Experiment Videos

  • New cytotoxic and cytostatic agents are being rigorously tested.

    • Conclusions:

    • Advanced clinical trial designs in companion animals will significantly improve veterinary oncology.
    • Findings from veterinary trials can provide valuable insights for future human clinical trials.